Biotech Startup Maze Therapeutics Strikes $750 Million Deal With Sanofi
Posted by amanda punzalan under Media (No Respond)
Archive for May, 2023
Sanofi bets $750M to enter glycogen-lined Maze deal with lead asset waiting in the middle
Posted by amanda punzalan under Media (No Respond)
Biotech Startup Maze Therapeutics Strikes $750 Million Deal With Sanofi
Posted by amanda punzalan under Media (No Respond)
Sanofi strikes a $150M deal for Maze’s Pompe disease drug
Posted by amanda punzalan under Media (No Respond)
Sanofi’s next chapter in Pompe: $150M for Maze pact as the biotech gears up in CKD
Posted by amanda punzalan under Media (No Respond)
Sanofi stock rises on licensing deal with Maze for potential Pompe disease drug
Posted by amanda punzalan under Media (No Respond)
Early clinical data drove Sanofi’s decision to license Maze’s oral Pompe therapy
Posted by amanda punzalan under Media (No Respond)
Sanofi pumps up its Pompe portfolio with Maze deal
Posted by amanda punzalan under Media (No Respond)
Sanofi Finds Way to Maze Therapeutics to Get Its Next Pompe Disease Drug
Posted by amanda punzalan under Media (No Respond)